Quantification of clonal circulating plasma cells in relapsed multiple myeloma (Q34416126)

2 August 2017

title

Quantification of clonal circulating plasma cells in relapsed multiple myeloma (English)

1 reference

2 August 2017

1 reference

6

Angela Dispenzieri

1 reference

2 August 2017

8

Martha Q Lacy

1 reference

2 August 2017

11

Morie A Gertz

1 reference

2 August 2017

7

Francis K Buadi

1 reference

2 August 2017

12

Shaji K Kumar

1 reference

2 August 2017

1

Wilson I Gonsalves

1 reference

2 August 2017

10

Prashant Kapoor

1 reference

2 August 2017

3

Vincent Rajkumar

1 reference

2 August 2017

William G Morice

2

1 reference

2 August 2017

Vinay Gupta

series ordinal

4

1 reference

2 August 2017

Michael M Timm

series ordinal

5

1 reference

2 August 2017

Preet P Singh

series ordinal

9

1 reference

2 August 2017

language of work or name

English

0 references

publication date

12 August 2014

1 reference

British Journal of Haematology

2 August 2017

published in

1 reference

2 August 2017

volume

167

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

500-505

1 reference

Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma.

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211997

Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211997

Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211997

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211997

Initial genome sequencing and analysis of multiple myeloma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211997

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211997

Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapie

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211997

The treatment of relapsed and refractory multiple myeloma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211997

Improved survival in multiple myeloma and the impact of novel therapies

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211997

International uniform response criteria for multiple myeloma.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211997

Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification system

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211997

Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211997

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211997

Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211997

Interaction of tumor and host cells with adhesion and extracellular matrix molecules in the development of multiple myeloma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211997

Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4211997

Clinical course of patients with relapsed multiple myeloma

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FBJH.13067

Impact of early relapse after auto-SCT for multiple myeloma.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FBJH.13067

Short progression-free survival predicts for poor overall survival in older patients with multiple myeloma treated upfront with novel agent-based therapy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FBJH.13067

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25113422

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Detection of myeloma cells in the peripheral blood by flow cytometry

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25113422

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25113422

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/BJH.13067

1 reference

2 August 2017

1 reference

2 August 2017

1 reference